The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 222.00
Bid: 221.50
Ask: 222.50
Change: -1.00 (-0.45%)
Spread: 1.00 (0.451%)
Open: 220.00
High: 224.00
Low: 220.00
Prev. Close: 223.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Rockhopper loss widens; Synectics inks new contract

Thu, 28th Sep 2023 15:08

(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Rockhopper Exploration PLC - Salisbury, England-based oil and gas exploration company - Pretax loss in the six months ended June 30 widens to USD2.6 million from USD749,000 a year prior as administrative expenses jump 40% to GBP2.1 million. Records no revenue in the half year compared to USD523,000 a year ago due to the ceasing of production. Says "the existing portfolio continues to be evaluated for further opportunities, but revenue and cost of sales are not expected to be material in the immediate future." Looking ahead, says work continues on refining a new lower cost development and financing plan for its Sea Lion project in the Falkland Islands.

----------

PureTech Health PLC - Boston-based biotechnology company - Says founded entity Karuna Therapeutics Inc submits new drug application to the US Food & Drug Administration for KarXT for the treatment of schizophrenia. Submission is sipported by efficacy and long-term safety data from a clinical program evaluating KarXT as a treatment for schizophrenia, PureTech says. In all three placebo-controlled trials, KarXT met its primary endpoint and demonstrated a "statistically significant and clinically meaningful reduction in Positive and Negative Syndrome Scale (PANSS) total score compared to placebo." As a founder of Karuna, PureTech retains an equity ownership and has rights to receive milestone payments upon the achievement of certain regulatory approvals and 20% of sublicense income. PureTech Chief Innovation Officer Eric Elenko says: "KarXT, which was invented at PureTech, showcases how we invent and advance novel medicines by giving new life to drugs that have validated pharmacology but had previously not reached patients due to an issue that is now addressable with our innovations. This NDA submission is also an important milestone for patients, as it could represent the first major advance for treating schizophrenia in over 50 years if approved by the FDA."

----------

Synectics PLC - Sheffield, England-based security and surveillance systems firm - Wins new contract with West Midlands Police for the use of its open software platform, Synergy. Has collaborated with the police force since 2005. Says additional contract will see the company integrate cameras operated by the National Highways Agency throughout the West Midlands into Synergy to increase multi-agency collaboration and improve incident response times. Chief Executive Officer Paul Webb says: "The inclusion of the regional camera network from the National Highways Agency will deliver even more comprehensive situational awareness for WMP. Integrating feeds from multiple agencies is a delicate and complex process, but with our technological expertise and compliance with protocols, we are able to deliver the end-to-end solution required by WMP."

----------

SpaceandPeople PLC - Glasgow-based retail, promotional and brand experience specialist - Subsidiary POP Retail GmbH agrees to provide retail kiosks to CEMAGG Management GmbH in its shopping centres in Germany. Chief Executive Officer Nancy Cullen says: "We are delighted to have signed this agreement with CEMAGG. It helps to further expand and consolidate our network of venues in Germany, it complements our recent agreement with Multi Germany GmbH and builds on our long-standing relationship with ECE, as well as demonstrating our focus on expanding our network of clients and venues in Europe."

----------

Atome Energy PLC - Leeds, England-based green hydrogen, ammonia, and fertilizer project development in Paraguay, Iceland, and Central America - Pretax loss in the six months ended June 30 widens to USD2.9 million from USD2.5 million a year prior, driven by a 16% increase in administrative expenses to GBP2.9m. Looking ahead, says the second half of the year is an "exciting time" for project progression, and views the outlook with "significant confidence."

----------

Cornish Metals Inc - Vancouver, Canada-based mineral exploration and development firm focused on the UK and North America - Begins wet commissioning of South Crofty mine water treatment plant in Cornwall. Says MWTP is designed to treat 25,000 metres cubed per day of water pumped directly from South Crofty mine and uses high density sludge process technology to treat raw mine water and meet the company's permitted standards for discharge into the nearby Red river. Says its project delivery team is being supported by the plant designer, equipment suppliers and contractors to "fully test and commission every aspect of the process before commencing discharge to the Red river." Expects commissioning and building of the high density sludge bed to take up to three weeks, with full dewatering of the mine anticipated to commence in October. Chief Executive Officer Richard Williams says: "The commencement of wet commissioning at the South Crofty MWTP is another exciting step towards the dewatering of South Crofty mine. Our project team, supported by a small army of dedicated local contractors, has worked extremely hard over the last 12 months to take the MWTP from a conceptual flowsheet design through to a fully constructed plant."

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
7 Oct 2022 07:10

Puretech Health confirms possible tie-up with Nektar Therapeutics

(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.

Read more
7 Oct 2022 07:10

Puretech Health confirms possible tie-up with Nektar Therapeutics

(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.

Read more
5 Sep 2022 11:40

IN BRIEF: PureTech Health data on fibrosis drug candidate positive

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Posts positive data from a phase 1 trial of its idiopathic pulmonary fibrosis drug candidate LYT-100, or deupirfenidone.

Read more
31 Aug 2022 20:31

TOP NEWS: ConvaTec to join FTSE 100 as abrdn vacates spot

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, September 19 after completing its quarterly review.

Read more
25 Aug 2022 16:26

TRADING UPDATES: Malvern revenue jumps; Rockwood eyes Main Market

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Aug 2022 11:03

SMALL-CAP WINNERS & LOSERS: Hunting surges as loss narrows, ups payout

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.

Read more
25 Aug 2022 10:10

IN BRIEF: PureTech Health loss narrows in "exceedingly strong" half

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Pretax loss in the first half 2022 narrows to USD56.0 million from USD94.9 million a year before. This is due to a USD28.4 million gain on the dilution of its equity interest in Gelesis Inc. Revenue grows 21% to USD7.0 million from USD5.8 million. Attributes this to increased grant revenue from the Vedanta CARB-X and BARDA grant, as well as Alivio and PureTech LYT Inc.

Read more
25 Aug 2022 09:25

PureTech first-half mixed as it makes good clinical progress

(Sharecast News) - PureTech Health reported total first-half revenue of $7.03m on Thursday, up from $5.84m year-on-year.

Read more
24 Aug 2022 17:58

IN BRIEF: PureTech Health's Sonde Health signs deal for COPD in India

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says its founded entity, Sonde Health, has signed a multi-year agreement with specialty pharmaceutical company Koye Pharmaceuticals Pvt Ltd. The agreement is to develop a new vocal biomarker detection and monitoring capability for chronic obstructive pulmonary disease in India. This is Sonde's first partnership with a pharmaceutical firm, PureTech adds.

Read more
23 Aug 2022 18:14

TOP NEWS: abrdn indicated to drop out of FTSE 100, F&C to join

(Alliance News) - Almost 18 months after announcing a name change, abrdn PLC's blue-chip status is under threat, according to indicative index changes provided by FTSE Russell on Tuesday.

Read more
22 Aug 2022 09:15

PureTech Health's Akili raises USD163 million via Nasdaq IPO

(Alliance News) - PureTech Health PLC said founded entity Akili Inc will start trading on the Nasdaq Capital Market on Monday, after raising funds which will go towards video-game based treatment for children.

Read more
9 Aug 2022 09:31

PureTech gets USD115 million from sale of Karuna Therapeutics shares

(Alliance News) - PureTech Health PLC on Tuesday announced it received USD115.4 million after selling a portion of its stake in Karuna Therapeutics Inc.

Read more
8 Aug 2022 17:06

LONDON MARKET CLOSE: Strong start to week as US inflation data looms

(Alliance News) - Stocks in London sprang into the new week after Friday's US jobs data lessened recession fears.

Read more
8 Aug 2022 16:21

IN BRIEF: PureTech shares jump on Karuna Therapeutics trial results

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says founded entity Karuna Therapeutics reports positive phase III trial results from Emergent-2 trial for KarXT in schizophrenia. KarXT, or xanomeline-trospium, met its primary endpoint in the trial, showing a significant 9.6 point reduction in Positive and Negative Syndrome Scale total score compared to a placebo. The PANSS scale measures the symptom severity of patients with schizophrenia. The trial also met key secondary endpoints, the firm says. Karuna plans to submit a new drug application with the US Food & Drug Administration in mid-2023.

Read more
1 Aug 2022 21:21

IN BRIEF: PureTech Health's Aliki starts phase three study for SDT-001

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Notes that founded entity Akili Interactive Labs Inc has start a pivotal phase three randomised, controlled study of SDT-001, a candidate designed to improve the measures of attention in children diagnosed with ADHD.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.